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Abstract: The aim of this study was to determine the changes in endurance performance and
metabolic, hormonal, and inflammatory markers induced by endurance stress (marathon race) in a
combined strategy of training and dietary protein supplementation. The study was designed as a
randomised controlled trial consisting of regular endurance training without and with a daily intake
of a soy protein-based supplement over a three-month period in 2 × 15 (10 males and 5 females
per group) endurance-trained adults. Body composition (body mass, BMI, and fat mass) was
determined, and physical fitness was measured by treadmill ergometry at baseline and after 3 months
of intervention; changes in exercise-induced stress and inflammatory markers (CK, myoglobin,
interleukin-6, cortisol, and leukocytes) were also determined before and after a marathon competition;
eating behaviour was documented before and after intervention by a three-day diet diary. Although
no significant influence on endurance performance was observed, the protein supplementation
regime reduced the exercise-induced muscle stress response. Furthermore, a protein intake of ≥20%
of total energy intake led to a lower-level stress reaction after the marathon race. In conclusion,
supplementary protein intake may influence exercise-induced muscle stress reactions by changing
cellular metabolism and inflammatory pathways.
Keywords: protein-rich diet; endurance exercise; muscle stress; inflammation
1. Introduction
It is well accepted that nutrition is a limiting factor in human performance and that
athletes should ensure that they meet their daily energy needs to balance their requirements
for energy expenditure [1]. Independent of total energy intake, the specific timing and
macronutrient composition of energy intake throughout the day has the potential to
modulate the body’s adaptation to exercise [2]. Furthermore, macronutrient composition
should be adapted to the regularly performed training or sport modality since different
sports have different energetic and nutritional requirements [3].
With respect to dietary protein, the supply of essential amino acids is critically linked
to muscle protein synthesis and can promote skeletal muscle hypertrophy in response to
chronic resistance training [4]. However, evidence linking protein intake to a benefit in
endurance sports has not been clearly established [5]. Authors have suggested that protein
intake during or immediately after exercise may induce an ergogenic effect on endurance
performance, preferably in combination with the intake of carbohydrates as the first-choice
energy supply [2,6–8]. Nevertheless, there remains no consensus on whether the metabolic
and systemic effects of proteins is simply a consequence of providing extra energy or rather,
may be a specific benefit regarding the protein source as well as to the intake of biological
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active peptides, which are also increasingly absorbed via the increased or targeted supply
of proteins [9–11].
Therefore, we performed a randomised controlled trial (RCT) involving a group of
experienced athletes to evaluate the effects of a combination of endurance training and a
regular intake of a protein-rich dietary supplement over a period of 3 months in preparation
for a marathon race. These athletes also partook in a local marathon at the end of the
intervention. The main aim of the study was to investigate whether the intake of the protein
supplement influences endurance performance and whether its supplementation reduces
exercise-induced muscular or systemic stress reactions.
2. Materials and Methods
2.1. Study Design
The study was designed as an experimental RCT to determine the effects of a protein-
rich supplementation regime across a 3-month training period on the endurance perfor-
mance and training adaptation, ultimately evaluated with a marathon race at the end of
the intervention compared to a control group. Participants study visits were conducted
at baseline (termed “a”) and at the end of the 3-month training intervention (termed “b”)
as well as before (termed “c”) and 1 h after (termed “d”) the marathon race at the end of
intervention. The period between visits “b” and “c” lasted approximately 7 days, but the
athletes had to continue with the protein supplementation regimen until the marathon
race day. After the “a" visit, study participants were randomly assigned either to the
intervention or control group.
2.2. Participants
After contacting and advertising the study protocol to regional sports clubs, 30 out
of 52 applicants met the criteria for randomisation (defined as experienced endurance
runners) to either a verum (V; n = 15, 10 males, 5 females) or a control group (C; n = 15,
10 males, 5 females). Participants had to fulfil the following inclusion criteria: to be clinically
healthy endurance-trained adults, aged between 18–60 years, and a body mass index (BMI)
between 18–25 kg/m2. Additional inclusion criteria were: constant roadwork training
(ca. 3 times per week of 25–30 km endurance training), non-use of other nutritional or
ergogenic supplements, no blood lipid- or glucose-lowering therapy within the preceding
12 months, being non-smoker, alcohol consumption <40 g/d, and a relative maximal oxygen
consumption (VO2max) between 45–65 mL/kg/min. The study protocol was registered
and approved by the Ethical Commission of the University of Freiburg (reg. no. 231/12).
The study was conducted in accordance with the ethical standards established in the 1964
Declaration of Helsinki and its later amendments [12]. All participants were informed
verbally and supported by a written participant information sheet, and signed consent to
participate in the study was obtained.
2.3. Protein Supplementation
The supplement used (comparable with the commercially available product Almased-
Vitalkost®; Almased-Wellness-GmbH, Bienenbüttel, Germany) is composed of soy protein,
skimmed milk powder, and honey without additives. The protein content of this product
is 53.3% (83% soy-protein-isolate, and 17% milk protein). Given the special marathon
conditions, each 50 g portion was supplemented with 9 g palatinose, 30 mg carnitine, 10 mg
coenzyme Q10, and 0.5 mg α-lipoic acid. One portion thereby equated to 60 g of powder
dissolved in 300 mL water, providing 217 kcal, 27.2 g protein, 24.6 g CHO, and 1.0 g fat.
Participants were instructed to drink one portion twice per day, in the morning before
breakfast and in the afternoon or evening, with each intake always approximately at the
same time of day and with a delay before ingestion of other meals to account for the low
glycaemic load of the product.
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2.4. Measures
The participants’ accordance with the inclusion criteria was confirmed in the initial
comprehensive health screening before the intervention. Laboratory analysis of blood
samples as well as the measurement of anthropometric parameters were concomitantly
performed. Anthropometry comprised body height (BH), body mass (BM), and body mass
index (BMI). BM was measured in light clothing to the nearest 0.1 kg, BH to the nearest
0.5 cm (Seca Stadiometer 274, Seca GmbH & Co. KG, Hamburg, Germany), and BMI was
calculated with the formula: weight in kilogram divided by height in meters squared.
Percentage body fat (FM%) was calculated using the Siri equation [13] with the log sum of
skinfold thickness (SFT) at 4 measuring sides (triceps, biceps, subscapular, and suprailia).
The SFT was measured using a skinfold calliper (Lange Skinfold Caliper, Beta Technology
Inc., Noblesville, IN, USA). The laboratory analyses included selected metabolic variables
for performance diagnostics (blood lactate concentration [14]), whole blood cell counts
(including leukocytes [15]), selected blood indicators of muscle damage and systemic
stress (creatine kinase (CK) [16], myoglobin [17] and interleukin-6 (IL-6) [18]), and the
hormone cortisol [19]. Biochemical blood variables were determined by venous blood
sampling. Leukocyte count, cortisol, and indicators of muscle damage and stress response
were utilised in the calculation of a “stress score” (unpublished “in-house” method to
determine overall exercise-induced stress response), which was expected to be noticeably
increased after bouts of hard endurance exercise, such as a marathon race. For this purpose,
the participants’ values for each of the variables were ranked in ascending order and
categorised into three equally sized groups. For each parameter, the participants were
assigned to one of the three categories, reaching a stress score of 1 for a relatively low
parameter increase, 2 for a moderate increase, and 3 for a high increase. Hence, for each
participant, a final total stress score was calculated ranging from a possible minimum
of 5, showing low levels for all 5 variables, to a maximum score of 15. Mean stress
scores were calculated for both study groups. The comprehensive health screening also
included performance diagnostics to assess the training status of the participants and
were conducted as a treadmill test using spiroergometric equipment (ZAN Messgeräte
GmbH, Oberthulba, Germany) following the ZAN protocol of sequential 3 min steps
with increasing running speed [14,20]. After each increment to the maximal possible
load (running speed max), a capillary blood sample was taken from the earlobe for blood
lactate concentration measurement as well as immediately after the termination of the
test to obtain the maximal blood lactate concentration. These lactate values were used to
calculate the individual anaerobic threshold (IAT) [21]. The running speeds at the described
thresholds were transformed into the theoretical time needed individually to reach 1000 m
(1000 m time at the IAT). Participants were tested 3 h after breakfast. Blood samples were
also drawn prior to performance diagnostics. In addition, the participants were requested
to avoid highly intensive physical activity and strength exercise on the previous day to
prevent post-training alterations in the pre-test blood samples acquired.
2.5. Training Phase
To estimate training compliance and comparability of training volume and exercise in-
tensity between the groups, the participants were requested to complete training protocols,
documenting weekly training distances and training time over the 12-week intervention
phase. The entire training phase was supervised by experienced endurance trainers in both
groups. Furthermore, participants were requested to complete a 3-day estimated nutrition
protocol before and after the intervention period and were advised to maintain their typical
eating and drinking patterns. The evaluation of the food records was performed using the
EBISpro nutrition system (Stuttgart, Germany) [22].
2.6. Statistics
Prior to analysis, data were checked for normality distribution. Intragroup compar-
isons between baseline and post-intervention as well as before and after the marathon race
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were assessed by the Wilcoxon signed-rank test. Intergroup comparisons were analysed
by the Mann–Whitney U test. Spearman’s rank correlation analysis was performed to
determine the influence of macronutrient intake on muscle stress reactions. The variables
“Diff. Myoglobin (µg/L)” and “Diff. CK (U/L)” were log transformed due to variance in-
homogeneity and the analyses (correlation, regression analysis and t-test) were conducted
with the transformed variables. SPSS 22.0 (SPSS Inc., Chicago, IL, USA) was used for the
statistical analysis. All statistical tests were two-sided, and the level of significance was set
at α = 0.05.
3. Results
From the 30 endurance athletes (verum group: n = 15, 10 males, 5 females; control
group: n = 15, 10 males, 5 females) recruited, 23 completed the 3-month intervention
period; no adverse event could be related to the given formula (verum group: 5 dropouts
(respiratory tract infection: n = 1, orthopaedic problems: n = 2, personal reasons: n = 2);
control group: 2 dropouts (orthopaedic problems: n = 1, personal reason: n = 1)). However,
21 of these 23 athletes were able to perform the marathon race over the complete distance
(2 dropouts because of muscle cramps) (Figure 1).




Figure 1. Study flowchart. Control group: endurance training intervention for 3 months. Verum 
group: endurance training plus protein-rich supplement for three months. 
Energy (EI) and macronutrient intakes (expressed as a percentage of EI and relative 
to BW) in the tested study groups at the beginning and the end of the intervention are 
presented in Supplementary Table S1. The intervention did not influence the total energy 
intake in either group. However, the supplement intake resulted in a significant increase 
in the relative and absolute protein intake in the verum group and yielded a significantly 
higher protein intake in the intergroup comparisons at the end of the intervention. Given 
the unchanged total energy intake, the increased protein intake in the verum group was 
associated with a significant decrease in relative fat intake across the course of interven-
tion.  
Performance and exercise-induced stress variables measured before and after the in-
tervention are shown in Table 2. There were no significant differences in the inter-group 
comparisons for any of these variables. As a result of the regular training sessions, both 
running time and running distance accumulated over the 12 weeks of intervention in both 
groups to a comparable extent (verum group: 3.100 ± 1000 min, 540 ± 230 km; control 
group: 2.810 ± 570 min, 571 ± 96 km). Aerobic performance showed a slight improvement 
of approximately 3% in both groups.  
Table 2. Performance and exercise-induced stress markers measured before (time point a) and after 
the intervention (time point b). 
Variable 
Verum (n = 10) Control (n = 13) 
a b a b 
Max. blood lactate concentration 
(mmol/L) 
8.80 ± 1.20 9.60 ± 1.50 9.20 ± 2.30 10.20 ± 3.60 
Running speed max (km/h) 16.4 ± 2.0 16.8 ± 1.9 15.9 ± 1.3 * 16.4 ± 1.5 
1000 m-time at the IAT (mm:ss) 04:59 ± 00:42 04:44 ± 00:52 05:12 ±00:31 04:41 ± 00:24 
Figure 1. Study flowchart. Control group: endurance training intervention for 3 months. Verum
group: endurance training plus protein-rich supplement for three months.
Basic and anthropometric characteristics of the study groups are presented in Table 1;
no significant differences were found in these variables in the intra- or inter-group com-
parisons. Most of the verum group participants achieved a daily protein intake greater
than 20% of the total energy intake, based on the 3-day diet diaries indicating intervention
compliance regarding the protein supplementation regime.
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Table 1. Basic and anthropometric characteristics of the study groups (verum, control) before (time
point a) and after the 3 months intervention period (time point b).
Variable
Verum (n = 10) Control (n = 13)
a b a b
Sex (m/f) 7/3 9/4
Age (y) 29.0 ± 11.0 28.6 ± 8.7
Body mass (kg) 73.7 ± 6.7 74.5 ± 8.2 71.1 ± 71.5 71.5 ± 8.8
BMI (kg/m2) 23.5 ± 1.2 23.3 ± 1.5 22.4 ± 2.1 22.5 ± 1.9
BFM (%BW) 22.9 ± 9.9 21.8 ± 8.9 22.2 ± 7.7 20.9 ± 7.8
Results are presented as mean ± SD. There were no statistical differences between both groups.
Energy (EI) and macronutrient intakes (expressed as a percentage of EI and relative
to BW) in the tested study groups at the beginning and the end of the intervention are
presented in Supplementary Table S1. The intervention did not influence the total energy
intake in either group. However, the supplement intake resulted in a significant increase
in the relative and absolute protein intake in the verum group and yielded a significantly
higher protein intake in the intergroup comparisons at the end of the intervention. Given
the unchanged total energy intake, the increased protein intake in the verum group was
associated with a significant decrease in relative fat intake across the course of intervention.
Performance and exercise-induced stress variables measured before and after the
intervention are shown in Table 2. There were no significant differences in the inter-group
comparisons for any of these variables. As a result of the regular training sessions, both
running time and running distance accumulated over the 12 weeks of intervention in both
groups to a comparable extent (verum group: 3.100 ± 1000 min, 540 ± 230 km; control
group: 2.810 ± 570 min, 571 ± 96 km). Aerobic performance showed a slight improvement
of approximately 3% in both groups.
Table 2. Performance and exercise-induced stress markers measured before (time point a) and after
the intervention (time point b).
Variable
Verum (n = 10) Control (n = 13)
a b a b
Max. blood lactate
concentration (mmol/L) 8.80 ± 1.20 9.60 ± 1.50 9.20 ± 2.30 10.20 ± 3.60
Running speed max
(km/h) 16.4 ± 2.0 16.8 ± 1.9 15.9 ± 1.3 * 16.4 ± 1.5
1000 m-time at the IAT
(mm:ss) 04:59 ± 00:42 04:44 ± 00:52 05:12 ±00:31 04:41 ± 00:24
VO2max (mL/min/kg) 51.8 ± 6.3 * 53.3 ± 5.9 50.4 ± 4.1 * 51.9 ± 4.9
CK (U/L) 140 ± 120 190 ± 150 170 ± 97 165 ± 95
Myoglobin (µg/L) 35.0 ± 50.0 30.0 ± 15.0 19.0 ± 7.1 18.2 ± 8.0
Leukocytes (1000/µL) 5.3 ± 0.9 5.0 ± 0.3 5.4 ± 1.3 5.2 ± 1.1
IL-6 (pg/mL) 2.0 ± 0.0 2.1 ± 0.2 2.0 ± 0.0 2.1 ± 0.2
Cortisol (ng/mL) 167.00 ± 31.00 206.00 ± 58.00 161.00 ± 36.00 * 195.00 ± 45.00
Results are presented as mean ± SD. * p < 0.05; CK, creatine kinase.
Acute exercise-induced stress markers before and 1 h after the marathon race are
shown in Table 3. Twenty-one participants completed the marathon race and were included
in the analysis. There was no difference in the marathon running time in the tested groups
(verum: 3:54 h ± 32 min; control: 3:59 h ± 26 min). Both groups showed significant
increases in all exercise-induced stress markers. There were trends toward higher calculated
increments for all stress markers in the control group. A significant inter-group difference
was found for serum myoglobin.
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Table 3. Exercise-induced stress values of the 21 participants who completed both the intervention and the marathon race
before (time point c) and after the race (time point d).
Variable
Verum (n = 9) Control (n = 12)
c d inc. F c d inc. F
CK (U/L) 122 ± 41 ** 530 ± 220 4 180 ± 110 ** 1400 ± 1300 8
Myoglobin (µg/L) 26.0 ± 15.0 ** 770 ± 540 † 29 † 32.0 ± 35.0 ** 2200 ± 1800 68
Leukocytes (1.000/µL) 5.3 ± 0.5 ** 15.8 ± 2.5 3.0 5.4 ± 1.1 ** 18.0 ± 4.2 3.3
IL-6 (pg/mL) 2.0 ± 0.0 ** 37.0 ± 30.0 18 2.0 ± 0.1 ** 43.0 ± 15.0 21.3
Cortisol (ng/mL) 184 ± 48.0 ** 302 ± 70.0 1.6 194 ± 48.0 ** 335 ± 95.0 1.7
Results are presented as mean ± SD. ** p < 0.01 (intra-group comparisons between time points). † p < 0.05 (inter-group comparison at time
point and for rise factor). Group-specific increment factor of the measured variables (inc. F.) was calculated as d/c. CK, creatine kinase.
Regression analyses among the increases in the measured stress variables and calcu-
lated stress score showed that there was a negative association between the individual
protein intake (expressed as a proportion of daily protein intake in the post-intervention
phase) and the increase in stress markers (significant difference in IL-6, cortisol, and stress
score; trend for difference in CK, myoglobin, and leukocytes) after the marathon race
(Table 4). The regression curves showed that with a daily protein intake (PI) of less than
20% of the total energy intake, the increase in stress markers was visibly higher. This
was statistically confirmed in a group comparison for the participants of the marathon in
relation to their protein intake (PI) (n = 12: PI < 20% vs. n = 9: PI = >20%) (Table 4). The
graphical representation based on the stress score (Figure 2) also showed that an increased
protein intake of more than 20% was achieved primarily by participants in the verum
group. In contrast to that of the protein intake, the regression analysis did not provide any
evidence for a relation between fat and carbohydrate intake and the exercise-induced stress
reaction.
Table 4. Differences in exercise-induced stress markers and the calculated stress score among the athletes who completed
the marathon race (n = 21) differentiated by their protein.
Variable PI < 20% (n = 12) PI ≥ 20% (n = 9) r (Diff.y = f(PI%)) Sign. r
∆ CK (U/L) 1.372 ± 1.242 521 ± 238 * −0.387 0.083
∆ Myoglobin (µg/L) 2.129 ± 1.770 838 ± 602 * −0.421 0.057
∆ Leukocytes (1.000/mL) 18.180 ± 3.920 15.160 ± 2.540 −0.411 0.064
IL−6 (pg/mL) 40.9 ± 16.2 31.0 ± 17.1 −0.476 0.034
Cortisol (ng/mL) 361 ± 90.4 278 ± 75.6 * −0.459 0.036
Stress score (U) 11.2 ± 2.12 8.2 ± 1.99 ** −0.667 0.001
Results are presented as mean ± SD. ** p < 0.01; * < 0.05 (PI < 20% vs. PI ≥ 20%). Differences in exercise-induced stress markers and the
calculated stress score among the athletes who completed the marathon race (n = 21) differentiated by their protein intake (PI, % per energy
intake per day) after the intervention and the correlation coefficients (protein % of daily energy intake vs. stress markers). CK, creatine
kinase.




Figure 2. Scatterplot showing a linear regression line for the negative association between the calculated stress score and 
protein intake (proportion of daily energy intake). 
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marathon race (n = 21) differentiated by their protein intake (PI, % per energy intake per day) after 
the intervention and the correlation coefficients (protein % of daily energy intake vs. stress mark-
ers). CK, creatine kinase. 
4. Discussion 
In the present RCT, intake of a protein-rich supplement during a 3-month training 
intervention led to a reduced acute stress response after an exhausting marathon race, 
which negatively correlated with the proportion of protein intake in relation to the daily 
energy intake. Furthermore, a threshold of approximately 20% of energy intake from pro-
tein appeared to be necessary to reduce the increase in stress markers to lower levels. 
Whilst protein supplementation can be beneficial for athletes in relation to protein syn-
thesis and reductions in muscle damage and enhanced recovery of muscle function [23], 
Figure 2. Scatterplot showing a linear regression line for the negative association between the calculated stress score and
protein intake (proportion of daily energy intake).
4. Discussion
In the present RCT, intake of a protein-rich supplement during a 3-month training
intervention led to a reduced acute stress response after an exhausting marathon race,
which negatively correlated with the proportion of protein intake in relation to the daily
energy intake. Furthermore, a threshold of approximately 20% of energy intake from
protein appeared to be necessary to reduce the increase in stress markers to lower levels.
Whilst protein supplementation can be beneficial for athletes in relation to protein synthesis
and reductions in muscle damage and enhanced recovery of muscle function [23], recently
published RCT’s have nevertheless demonstrated that acute (1–3 days prior of exhausting
exercise) [24], and post-exercise [25,26] protein supplementation is not superior compared
to other types of dietary supplementation (e.g., carbohydrate supplementation) in order to
attenuate exercise-induced muscle damage or systemic inflammatory processes. However,
chronic protein supplementation for at least 1 month prior to an exhausting bout of exer-
cise [27], which is consistent with the present findings, has been shown to induce beneficial
effects on markers of muscle damage and inflammation. Apart from the influence of the
supplementation duration prior to strenuous exercise, there are additional factors (e.g.,
training status (untrained vs. trained) or modality (resistance vs. endurance exercise)) that
may impact the effect of the protein supplementation [28]. In the case of training modality,
both types, endurance and resistance exercise accompanied by protein supplementation,
can support positive adaptive responses in protein synthesis and reductions in muscle
damage and enhanced recovery of muscle function [17,28,29].
The threshold of at least 20% of energy intake from protein sources in the present
study points towards a dose-response pattern for protein supplementation. This finding is
consistent with the current opinion that active individuals attempting to optimize training
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adaptations need to increase their protein intake from a typical level of 0.8 g/kg/day to at
least 1.4–1.6 g/kg/day [30]. In addition to the quantitative aspect, qualitative aspects of the
protein source may also be important, e.g., in relation to the uptake of biologically active
peptides, which may have supported biological functions in the present study [31–33]. Fur-
thermore, with respect to the regulation of anti-oxidative and anti-inflammatory actions,
the role of isoflavones (which are a well-characterised component of the soy protein sup-
plement) must be considered, as the protein supplement contains an amount of biologically
available isoflavonoids of approximately 1.5 mg per g of dried powder. This intake may be
at a level sufficient to produce biologically significant increases in blood isoflavone levels
and potentially confer metabolic and anti-oxidative benefits [34]. As the study participants
showed comparable exercise performance and were well prepared for the marathon race,
the differences could not be explained either by their adaptation to endurance exercise or
by the intensity, duration, and mode of the exercise performed [15,35].
The protein supplementation regime affected neither the training-induced improve-
ment in the performance markers measured after intervention nor the marathon running
time between the tested groups. These findings can be explained by the adaptation to the
regularly performed endurance training before the study, as all participants were profes-
sionally orientated runners [14,20]. Conversely, both groups were equally supervised by
licenced athletic and endurance trainers throughout the entire training phase. Another
explanation may be that the additionally supplemented ergogenic aids of carnitine, coen-
zyme Q10, and α-lipoic acid abolished possible inter-group differences. In this case, it must
be considered that the amount of the additives consumed was only in the range of the
assumed daily requirement and not at the level provided in food supplements available on
the market with the claim of improving aerobic performance. Thus, the results of this study
do not support the assumption of an ergogenic effect of protein supplementation and most
ergogenic aids in trained individuals accustomed to endurance sports, but instead agree
with the position statement of the ACSM regarding nutrition and athletic performance
Furthermore, high carbohydrate intake in the preparation as well as during an endurance
event remain as the best-documented factor for endurance performance [36–39].
The following strengths and limitations should be considered when interpreting the
data. We were able to motivate 30 long distance running experienced participants to
partake in the study [1,30]. However, based on the small sample size, any tendencies in
outcomes observed between both groups did not reach statistical significance and can
only be interpreted with caution as possible trends. In addition, it must be considered for
the quality of the study because it was not conducted using a placebo-controlled design
since it was impossible to produce a placebo supplementation formula without the main
components but with a comparable taste and appearance as well as caloric content. Future
studies with a similar study design but a larger sample size should be conducted to confirm
the current results.
5. Conclusions
The present findings indicate that a protein-rich supplementation regime attenuates
exercise-induced muscular and inflammatory stress responses and protects against a possi-
bly insufficient daily protein intake by endurance athletes during the training period. The
correlations between protein intake and acute exercise-induced stress markers appear to
be of relevance for the training of endurance athletes in that the extent of muscle damage
and accompanying inflammatory response can be interpreted as a predictor of subsequent
delayed-onset muscle soreness and may be attenuated by protein-rich nutrition.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/nu13092929/s1, Table S1: Energy (EI) and macronutrient intake (expressed as a percentage of
EI and relative to BW) in the tested study groups (Verum, Control) at the beginning (time point a)
and end (time point b) of the intervention.
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